"Designing Growth Strategies is in our DNA"

U.S. Hepatitis B Vaccine Market Size, Share & Industry Analysis, By Type (Single Antigen and Combination), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108637

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Hepatitis B, 2023
    2. Pipeline Analysis
    3. Recent Product Launches, By Key Players
    4. Key Industry Developments - Mergers, Acquisition, and Partnerships, etc.
    5. Impact of COVID-19 on the Market
  5. U.S. Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Single Antigen
      2. Combination Vaccine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals & Clinics
      2. Government Suppliers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. DYNAVAX TECHNOLOGIES CORPORATION
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      3. VBI Vaccines Inc.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      4. Sanofi
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      5. Merck & Co., Inc.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      6. Valneva SE
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      7. Shionogi & Co., Ltd.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      8. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Hepatitis B, 2023
    2. Pipeline Analysis
    3. Recent Product Launches, By Key Players
    4. Key Industry Developments - Mergers, Acquisition, and Partnerships, etc.
    5. Impact of COVID-19 on the Market
  5. U.S. Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Single Antigen
      2. Combination Vaccine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals & Clinics
      2. Government Suppliers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. DYNAVAX TECHNOLOGIES CORPORATION
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      3. VBI Vaccines Inc.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      4. Sanofi
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      5. Merck & Co., Inc.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      6. Valneva SE
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      7. Shionogi & Co., Ltd.
        1. GSK plc
        2. Overview
        3. Products
        4. SWOT Analysis
        5. Recent Developments
        6. Strategies
        7. Financials (Based on Availability)
      8. Other Prominent Players
Read Less

Table 01: U.S. Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02: U.S. Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Figure 01: U.S. Hepatitis B Vaccine Market Revenue Breakdown (USD billion, %) by Type, 2023 & 2032

Figure 02: U.S. Hepatitis B Vaccine Market Value Share (%), By Type, 2023 & 2032

Figure 03: U.S. Hepatitis B Vaccine Market Value Share (%), By Distribution Channel, 2023 & 2032

Figure 04: U.S. Hepatitis B Vaccine Market Share Analysis (%), By Company, 2023

U.S. Hepatitis B Vaccine Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 60
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports